Radioiodine‐Refractory Differentiated Thyroid Cancer: Definition, Molecular Mechanisms, and Advances in Precision Therapy

Yamin Li, Zuoxiang He · 2026

Read Radioiodine‐Refractory Differentiated Thyroid Cancer: Definition, Molecular Mechanisms, and Advances in Precision Therapy by Yamin Li, Zuoxiang He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13519041.txt.

Description

Yamin Li and Zuoxiang He review thyroid cancers that stop responding to radioactive iodine treatment, in a paper dated twenty twenty-six. Such cancers cause most thyroid cancer deaths, and survival with spread disease is near ten percent at ten years. Experts still disagree on the exact definition of this state. The review traces how gene changes silence the cell part that pulls iodine in.

Care has shifted over the last decade toward targeted drugs that block vessel growth and faulty growth switches. Some drug pairs can wake iodine uptake again in chosen patients. Immune drugs help a rare subgroup. The authors sort options by gene driver and proof level, and note that patient burden gets less space in most reviews.

Catalog record

CREATORYamin Li, Zuoxiang He
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13519041

Browse the full library · About the Tower of Babel